936 related articles for article (PubMed ID: 29535165)
1. Endoplasmic Reticulum Protein TXNDC5 Augments Myocardial Fibrosis by Facilitating Extracellular Matrix Protein Folding and Redox-Sensitive Cardiac Fibroblast Activation.
Shih YC; Chen CL; Zhang Y; Mellor RL; Kanter EM; Fang Y; Wang HC; Hung CT; Nong JY; Chen HJ; Lee TH; Tseng YS; Chen CN; Wu CC; Lin SL; Yamada KA; Nerbonne JM; Yang KC
Circ Res; 2018 Apr; 122(8):1052-1068. PubMed ID: 29535165
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast-enriched endoplasmic reticulum protein TXNDC5 promotes pulmonary fibrosis by augmenting TGFβ signaling through TGFBR1 stabilization.
Lee TH; Yeh CF; Lee YT; Shih YC; Chen YT; Hung CT; You MY; Wu PC; Shentu TP; Huang RT; Lin YS; Wu YF; Lin SJ; Lu FL; Tsao PN; Lin TH; Lo SC; Tseng YS; Wu WL; Chen CN; Wu CC; Lin SL; Sperling AI; Guzy RD; Fang Y; Yang KC
Nat Commun; 2020 Aug; 11(1):4254. PubMed ID: 32848143
[TBL] [Abstract][Full Text] [Related]
3. Endoplasmic reticulum protein TXNDC5 promotes renal fibrosis by enforcing TGF-β signaling in kidney fibroblasts.
Chen YT; Jhao PY; Hung CT; Wu YF; Lin SJ; Chiang WC; Lin SL; Yang KC
J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33465051
[TBL] [Abstract][Full Text] [Related]
4. The novel role of ER protein TXNDC5 in the pathogenesis of organ fibrosis: mechanistic insights and therapeutic implications.
Hung CT; Tsai YW; Wu YS; Yeh CF; Yang KC
J Biomed Sci; 2022 Sep; 29(1):63. PubMed ID: 36050716
[TBL] [Abstract][Full Text] [Related]
5. Bone Morphogenetic Protein 9 Reduces Cardiac Fibrosis and Improves Cardiac Function in Heart Failure.
Morine KJ; Qiao X; York S; Natov PS; Paruchuri V; Zhang Y; Aronovitz MJ; Karas RH; Kapur NK
Circulation; 2018 Jul; 138(5):513-526. PubMed ID: 29487140
[TBL] [Abstract][Full Text] [Related]
6. Targeting ER protein TXNDC5 in hepatic stellate cell mitigates liver fibrosis by repressing non-canonical TGFβ signalling.
Hung CT; Su TH; Chen YT; Wu YF; Chen YT; Lin SJ; Lin SL; Yang KC
Gut; 2022 Sep; 71(9):1876-1891. PubMed ID: 34933915
[TBL] [Abstract][Full Text] [Related]
7. NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts.
Cucoranu I; Clempus R; Dikalova A; Phelan PJ; Ariyan S; Dikalov S; Sorescu D
Circ Res; 2005 Oct; 97(9):900-7. PubMed ID: 16179589
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide adenine dinucleotide phosphate oxidase 4 mediates the differential responsiveness of atrial versus ventricular fibroblasts to transforming growth factor-β.
Yeh YH; Kuo CT; Chang GJ; Qi XY; Nattel S; Chen WJ
Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):790-8. PubMed ID: 23884197
[TBL] [Abstract][Full Text] [Related]
9. Protective Effects of Activated Myofibroblasts in the Pressure-Overloaded Myocardium Are Mediated Through Smad-Dependent Activation of a Matrix-Preserving Program.
Russo I; Cavalera M; Huang S; Su Y; Hanna A; Chen B; Shinde AV; Conway SJ; Graff J; Frangogiannis NG
Circ Res; 2019 Apr; 124(8):1214-1227. PubMed ID: 30686120
[TBL] [Abstract][Full Text] [Related]
10. Fibulin-2 is essential for angiotensin II-induced myocardial fibrosis mediated by transforming growth factor (TGF)-β.
Khan SA; Dong H; Joyce J; Sasaki T; Chu ML; Tsuda T
Lab Invest; 2016 Jul; 96(7):773-83. PubMed ID: 27111286
[TBL] [Abstract][Full Text] [Related]
11. Multiscale Analysis of Extracellular Matrix Remodeling in the Failing Heart.
Perestrelo AR; Silva AC; Oliver-De La Cruz J; Martino F; Horváth V; Caluori G; Polanský O; Vinarský V; Azzato G; de Marco G; Žampachová V; Skládal P; Pagliari S; Rainer A; Pinto-do-Ó P; Caravella A; Koci K; Nascimento DS; Forte G
Circ Res; 2021 Jan; 128(1):24-38. PubMed ID: 33106094
[TBL] [Abstract][Full Text] [Related]
12. Raf kinase inhibitor protein mediates myocardial fibrosis under conditions of enhanced myocardial oxidative stress.
Kazakov A; Hall RA; Werner C; Meier T; Trouvain A; Rodionycheva S; Nickel A; Lammert F; Maack C; Böhm M; Laufs U
Basic Res Cardiol; 2018 Sep; 113(6):42. PubMed ID: 30191336
[TBL] [Abstract][Full Text] [Related]
13. Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-β R II during TGF-β1-induced fibrogenesis in human cardiac fibroblasts.
Zou M; Wang F; Gao R; Wu J; Ou Y; Chen X; Wang T; Zhou X; Zhu W; Li P; Qi LW; Jiang T; Wang W; Li C; Chen J; He Q; Chen Y
Sci Rep; 2016 Apr; 6():24747. PubMed ID: 27098600
[TBL] [Abstract][Full Text] [Related]
14. Cardiac Fibroblast-Specific Activating Transcription Factor 3 Protects Against Heart Failure by Suppressing MAP2K3-p38 Signaling.
Li Y; Li Z; Zhang C; Li P; Wu Y; Wang C; Bond Lau W; Ma XL; Du J
Circulation; 2017 May; 135(21):2041-2057. PubMed ID: 28249877
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
Alex L; Russo I; Holoborodko V; Frangogiannis NG
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
[TBL] [Abstract][Full Text] [Related]
16. Cetuximab enhances cisplatin-induced endoplasmic reticulum stress-associated apoptosis in laryngeal squamous cell carcinoma cells by inhibiting expression of TXNDC5.
Peng F; Zhang H; Du Y; Tan P
Mol Med Rep; 2018 Mar; 17(3):4767-4776. PubMed ID: 29328423
[TBL] [Abstract][Full Text] [Related]
17. Cartilage intermediate layer protein-1 alleviates pressure overload-induced cardiac fibrosis via interfering TGF-β1 signaling.
Zhang CL; Zhao Q; Liang H; Qiao X; Wang JY; Wu D; Wu LL; Li L
J Mol Cell Cardiol; 2018 Mar; 116():135-144. PubMed ID: 29438665
[TBL] [Abstract][Full Text] [Related]
18. The redox regulator sulfiredoxin forms a complex with thioredoxin domain-containing 5 protein in response to ER stress in lung cancer cells.
Chawsheen HA; Jiang H; Ying Q; Ding N; Thapa P; Wei Q
J Biol Chem; 2019 May; 294(22):8991-9006. PubMed ID: 31000628
[TBL] [Abstract][Full Text] [Related]
19. IMM-H007 improves heart function via reducing cardiac fibrosis.
Ge W; Zhang W; Gao R; Li B; Zhu H; Wang J
Eur J Pharmacol; 2019 Aug; 857():172442. PubMed ID: 31181209
[TBL] [Abstract][Full Text] [Related]
20. Lumican is increased in experimental and clinical heart failure, and its production by cardiac fibroblasts is induced by mechanical and proinflammatory stimuli.
Engebretsen KV; Lunde IG; Strand ME; Waehre A; Sjaastad I; Marstein HS; Skrbic B; Dahl CP; Askevold ET; Christensen G; Bjørnstad JL; Tønnessen T
FEBS J; 2013 May; 280(10):2382-98. PubMed ID: 23480731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
